We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$911M
1-Year Est. Return
51.11%
This Fund
S&P 500
This Quarter
Est. Return
+13.65%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.18B
AUM Growth
+$363M
(+20%)
Cap. Flow
+$189M
Cap. Flow
% of AUM
8.65%
Top 10 Holdings %
Top 10 Hldgs %
46.28%
Holding
149
New
49
Increased
29
Reduced
25
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$72.1M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$54M |
| 3 |
International Paper
IP
|
+$45.3M |
| 4 |
APA Corp
APA
|
+$41.6M |
| 5 |
Heron Therapeutics
HRTX
|
+$33.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$39.7M |
| 2 |
Charter Communications
CHTR
|
+$37M |
| 3 |
Newell Brands
NWL
|
+$34.9M |
| 4 |
NFX
Newfield Exploration
NFX
|
+$27.8M |
| 5 |
Advance Auto Parts
AAP
|
+$26.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.04% |
| 2 | Consumer Staples | 12.64% |
| 3 | Consumer Discretionary | 8.59% |
| 4 | Energy | 6.82% |
| 5 | Communication Services | 5.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLCD
76
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $5.91M | 0.27% |
+154,963
| New | +$2.29M |
|
|
ARAV
77
DELISTED
Aravive, Inc. Common Stock
ARAV
| $5.89M | 0.27% |
80,176
+27,469
| +52% | +$1.98M |
|
78
Hope Bancorp
HOPE
$1.81B
| $5.5M | 0.25% |
+316,339
| New | +$5.12M |
|
|
KLXI
79
DELISTED
KLX Inc.
KLXI
| $5.32M | 0.24% |
+179,333
| New | +$5.16M |
|
80
Constellation Brands
STZ
$22.4B
| $5.13M | 0.24% |
+30,790
| New | +$5.08M |
|
|
ENTL
81
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $5.07M | 0.23% |
228,647
+3,367
| +1% | +$63.2K |
|
|
TSRO
82
CALL
DELISTED
TESARO, Inc.
TSRO
| $5.02M | 0.23% |
50,100
+25,100
| +100% | +$2.34M |
|
83
Gilead Sciences
GILD
$163B
| $4.64M | 0.21% |
+58,668
| New | +$4.77M |
|
|
ALPN
84
DELISTED
Alpine Immune Sciences Inc
ALPN
| $4.4M | 0.2% |
135,425
| – | – |
|
85
Virtu Financial
VIRT
$5.2B
| $4.32M | 0.2% |
+288,408
| New | +$4.86M |
|
|
NOVN
86
DELISTED
Novan, Inc. Common Stock
NOVN
| $3.99M | 0.18% |
+19,794
| New | +$4.14M |
|
|
ZLTQ
87
PUT
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $3.92M | 0.18% |
+100,000
| New | +$3.57M |
|
|
AERI
88
PUT
DELISTED
Aerie Pharmaceuticals
AERI
| $3.77M | 0.17% |
+100,000
| New | +$2.21M |
|
89
CALL
Emergent Biosolutions
EBS
$382M
| $3.26M | 0.15% |
+103,400
| New | +$3M |
|
90
PUT
Sarepta Therapeutics
SRPT
$1.68B
| $3.07M | 0.14% |
+50,000
| New | +$1.51M |
|
91
HCA Healthcare
HCA
$88B
| $3.06M | 0.14% |
40,496
+14,744
| +57% | +$1.13M |
|
92
Targa Resources
TRGP
$56.8B
| $2.97M | 0.14% |
60,400
-277,775
| -82% | -$12.1M |
|
93
Kroger
KR
$35.7B
| $2.94M | 0.14% |
+99,200
| New | +$3.3M |
|
|
ATRS
94
DELISTED
Antares Pharma, Inc.
ATRS
| $2.73M | 0.13% |
1,626,738
+347,870
| +27% | +$426K |
|
95
Great Elm Group
GEG
$74M
| $2.56M | 0.12% |
545,020
| – | – |
|
|
ASRT
96
PUT
DELISTED
Assertio
ASRT
| $2.5M | 0.11% |
+1,667
| New | +$2.09M |
|
97
PUT
Infosys
INFY
$49.6B
| $2.18M | 0.1% |
+276,200
| New | +$2.28M |
|
|
CBAY
98
DELISTED
Cymabay Therapeutics
CBAY
| $1.86M | 0.09% |
958,822
| – | – |
|
|
SIOX
99
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.74M | 0.08% |
+15,524
| New | +$1.86M |
|
100
CALL
AstraZeneca
AZN
$245B
| $1.7M | 0.08% |
25,850
+200
| +0.8% | +$13.1K |
|
Similar funds
GC
ICP
NAM
SAA
GIG
SI
PAMI
BDP
Kingdon Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Kingdon Capital Management held 149 positions worth $2.18B, up 20% from $1.82B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Kingdon Capital Management deployed $189M of net new capital in Q3 2016, opening 49 new positions and adding to 29 existing holdings. Its largest new stake was Amazon: 1,883,140 shares worth $78.8M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 12% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Newell Brands, an estimated $34.9M trimmed.
- Kingdon Capital Management's largest Q3 2016 buy was Amazon: 1,883,140 shares worth $78.8M.
- Kingdon Capital Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2016, an estimated $54M increase.
- Kingdon Capital Management's biggest Q3 2016 reduction was Newell Brands, cutting an estimated $34.9M.
- Kingdon Capital Management fully exited EMC CORPORATION in Q3 2016, selling an estimated $39.7M.
- Kingdon Capital Management's ten largest holdings make up 46% of its $2.18B portfolio in Q3 2016.
- Kingdon Capital Management opened 49 new positions and closed 33 in Q3 2016.
- Kingdon Capital Management's portfolio value rose 20% quarter-over-quarter to $2.18B.
Based on Kingdon Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.